Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy
Unknown statusPhase 4NCT00129597
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Prevalence of chronic pain after mastectomy is beyond 50% 3 months after surgery. This pain is related to a sensitization of the central nervous system through N-methyl-D-asparate (NMDA) receptors. Ketalar might prevent the occurrence of chronic pain by anti-NMDA properties after mastectomy.
Study details
- Official title
- Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy
- Conditions
- Interventions
- Drug: ketalar
- Sponsor
- Hospices Civils de Lyon
- Start date
- 2004-12
- Sex
- Female
- Age range
- from 18 Years to 80 Years
- Results posted
- No results posted in this snapshot
- Countries
- France
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Mastectomy in patients 18 to 80 years old Exclusion Criteria: * American Society of Anesthesiology (ASA) class \>= 3 * Renal, heart or hepatic failure * Allergy to ketalar * Psychiatric disease * Chronic antalgic treatment
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT00129597